La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Andromeda Metals Croissance future
Future contrôle des critères 0/6
Andromeda Metals is forecast to grow earnings and revenue by 67% and 149.3% per annum respectively while EPS is expected to grow by 72.2% per annum.
Informations clés
67.0%
Taux de croissance des bénéfices
72.2%
Taux de croissance du BPA
Metals and Mining croissance des bénéfices | 14.4% |
Taux de croissance des recettes | 149.3% |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Low |
Dernière mise à jour | 28 Jul 2024 |
Mises à jour récentes de la croissance future
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
6/30/2026 | 41 | 4 | -18 | 8 | 1 |
6/30/2025 | N/A | -8 | -90 | -4 | 1 |
6/30/2024 | N/A | -7 | -9 | -6 | 1 |
12/31/2023 | N/A | -10 | -16 | -8 | N/A |
9/30/2023 | N/A | -10 | -17 | -9 | N/A |
6/30/2023 | N/A | -9 | -18 | -9 | N/A |
3/31/2023 | N/A | -9 | -16 | -8 | N/A |
12/31/2022 | N/A | -9 | -14 | -7 | N/A |
9/30/2022 | N/A | -9 | -12 | -6 | N/A |
6/30/2022 | N/A | -9 | -10 | -5 | N/A |
3/31/2022 | N/A | -8 | -10 | -4 | N/A |
12/31/2021 | N/A | -8 | -9 | -4 | N/A |
9/30/2021 | N/A | -7 | -8 | -3 | N/A |
6/30/2021 | N/A | -6 | -7 | -2 | N/A |
3/31/2021 | N/A | -5 | -7 | -2 | N/A |
12/31/2020 | N/A | -4 | -6 | -2 | N/A |
9/30/2020 | N/A | -4 | -5 | -1 | N/A |
6/30/2020 | N/A | -3 | -4 | -1 | N/A |
3/31/2020 | 0 | -3 | -3 | -1 | N/A |
12/31/2019 | 0 | -3 | -2 | -1 | N/A |
9/30/2019 | 0 | -2 | -2 | -1 | N/A |
6/30/2019 | N/A | -1 | -2 | -1 | N/A |
3/31/2019 | 0 | -1 | -2 | -1 | N/A |
12/31/2018 | 0 | -1 | -2 | -1 | N/A |
9/30/2018 | 0 | -1 | -2 | -1 | N/A |
6/30/2018 | 0 | -1 | -1 | -1 | N/A |
3/31/2018 | 0 | -2 | -1 | -1 | N/A |
12/31/2017 | 0 | -3 | -1 | -1 | N/A |
9/30/2017 | 0 | -5 | N/A | -1 | N/A |
6/30/2017 | N/A | -7 | N/A | -1 | N/A |
3/31/2017 | N/A | -7 | N/A | -1 | N/A |
12/31/2016 | N/A | -7 | N/A | -1 | N/A |
9/30/2016 | N/A | -5 | N/A | -1 | N/A |
6/30/2016 | N/A | -4 | N/A | -1 | N/A |
3/31/2016 | 0 | -3 | N/A | -1 | N/A |
12/31/2015 | 0 | -1 | N/A | -1 | N/A |
9/30/2015 | 0 | -1 | N/A | -1 | N/A |
6/30/2015 | 0 | -1 | N/A | -1 | N/A |
3/31/2015 | 0 | -4 | N/A | -1 | N/A |
12/31/2014 | 0 | -7 | N/A | -1 | N/A |
9/30/2014 | 0 | -7 | N/A | -1 | N/A |
6/30/2014 | 0 | -7 | N/A | -1 | N/A |
3/31/2014 | 0 | -4 | N/A | -1 | N/A |
12/31/2013 | 0 | -1 | N/A | -1 | N/A |
9/30/2013 | 0 | -4 | N/A | -1 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: ADN is forecast to remain unprofitable over the next 3 years.
Bénéfices vs marché: ADN is forecast to remain unprofitable over the next 3 years.
Croissance élevée des bénéfices: ADN is forecast to remain unprofitable over the next 3 years.
Chiffre d'affaires vs marché: ADN is forecast to have no revenue next year.
Croissance élevée des revenus: ADN is forecast to have no revenue next year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if ADN's Return on Equity is forecast to be high in 3 years time